---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-015722"
form_type: "8-K"
ticker: "PROK"
cik: "0001850270"
company_name: "PROKIDNEY CORP."
filed_at: "2024-01-26T23:59:59+00:00"
generated_at: "2026-06-06T16:42:24.000747+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ProKidney releases updated corporate presentation; no specific financial or clinical updates

## Summary
- Company filed an updated investor presentation under Item 7.01 for January 2024.
- Presentation highlights REACT renal autologous cell therapy for dialysis prevention.
- No new financial data, clinical trial results, or guidance changes were disclosed.
- Presentation is available on the company's investor relations website.

## SEC filing metadata
- accession: 0001193125-24-015722
- form_type: 8-K
- ticker: PROK
- cik: 0001850270
- company_name: PROKIDNEY CORP.
- filed_at: 2024-01-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850270/000119312524015722/0001193125-24-015722-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850270/000119312524015722/d182870d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-015722
- JSON: https://secwatch.observer/filing/0001193125-24-015722.json
- Plain text: https://secwatch.observer/filing/0001193125-24-015722.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.